ARCHIVES

CIS Cost Sharing Feasibility Study Recommended

This article is from The Cancer Letter archive.

Vol. 13 No. 48 | December 11, 1987

Download PDF Visit The Full Archive

Related Articles

SWOG Opens Phase II Trial Of CuraGen’s HDAC Inhibitor For B-Cell Lymphoma

September 29, 2006

NCI Clarifies P01 Grant Application Dates

September 13, 1996

First Formal CREG Guidelines, Rules Publishes

June 6, 1975

ODAC Votes for Marqibo Accelerated Approval

March 30, 2012

In Brief: Baylor Recruits Scardino, Osborne, 13 Others; Likely To Gain Its Second NCI SPORE Grants

April 30, 1999

Rewritten Five Year Plan For Centers Is Greeted Warmly By NCAB Committee

April 27, 1990